Trulieve Cannabis Corp. (TCNNF)
Trulieve Cannabis Corp. (TCNNF)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss (gain) on debt extinguishments, net | NaN | -1,723 | NaN | NaN |
| Net income (loss) | 2,283 | -43,594 | -28,784 | -49,870 |
| Impairment and other charges, net of (recoveries) | NaN | 2,355 | 2,647 | -175 |
| Depreciation and amortization | 29,743 | 29,422 | 29,456 | 58,755 |
| Depreciation included in cost of goods sold | 13,989 | 14,244 | 13,949 | 27,577 |
| Deferred income taxes | NaN | -18,552 | NaN | NaN |
| (gain) loss on disposal or impairment of assets | 282 | NaN | NaN | NaN |
| Impairment of goodwill | NaN | 0 | NaN | NaN |
| Gain from disposal of discontinued operations | 7 | 826 | NaN | NaN |
| Share-based compensation | 4,137 | 3,976 | 5,785 | 10,705 |
| Proceeds received from insurance for operating expenses | NaN | 0 | 0 | 5,731 |
| Deferred income taxes | 6,452 | NaN | -4,747 | -9,919 |
| Other non-cash changes | -3,204 | -4,177 | -3,695 | -12,258 |
| Inventories | 22 | -992 | 1,827 | 10,093 |
| Accounts receivable | 3,852 | 328 | 28 | 3,368 |
| Other assets | 2,358 | -2,417 | -4,740 | 1,391 |
| Accounts payable and accrued liabilities | -8,745 | 294 | 256 | -11,813 |
| Income tax receivable / payable | 1,707 | -1,086 | -68 | 2,705 |
| Uncertain tax position liabilities | 28,016 | 52,060 | 56,649 | 114,445 |
| Other liabilities | -3,893 | -2,724 | -4,949 | -8,716 |
| Net cash provided by operating activities | 55,706 | 59,216 | 76,774 | 136,831 |
| Purchases of property and equipment | NaN | 3,411 | 12,329 | 28,453 |
| Purchases of internal use software | NaN | 3,691 | 4,271 | 8,355 |
| Purchases of short-term investments | NaN | 0 | 0 | NaN |
| Capital expenditures | 13,484 | NaN | NaN | NaN |
| Maturities of short-term investments | 0 | 0 | -393 | 60,393 |
| Other proceeds | 296 | 1,208 | 1,521 | 11,399 |
| Other purchases and payments | 0 | 0 | -88 | 205 |
| Net cash (used in) provided by investing activities | -13,188 | -5,894 | -15,384 | 34,779 |
| Proceeds from private placement notes | NaN | 140,000 | NaN | NaN |
| Proceeds from long-term borrowings | 60,742 | NaN | NaN | NaN |
| Payments on long-term borrowings | 2,046 | 385,880 | 2,013 | 5,455 |
| Proceeds from equity exercises | NaN | NaN | 0 | 0 |
| Other proceeds | NaN | 0 | 0 | 0 |
| Payments for debt issuance costs | 1,287 | 3,281 | NaN | NaN |
| Other payments and distributions | 2,582 | 1,877 | 2,563 | 4,583 |
| Payments for taxes related to net share settlement of equity awards | 0 | 4,354 | 196 | 295 |
| Net cash provided by (used in) financing activities | 54,827 | -255,392 | -4,772 | -10,333 |
| Net increase in cash and cash equivalents | 97,345 | -202,070 | 56,618 | 161,277 |
| Cash, cash equivalents, and restricted cash, beginning of period | NaN | 457,605 | 239,710 | NaN |
| Less cash and cash equivalents of discontinued operations, end of period | NaN | 0 | NaN | NaN |
| Cash, cash equivalents, and restricted cash, end of period | NaN | 255,535 | 457,605 | NaN |